Evaluation and subsequent minimization of matrix effects caused by phospholipids in LC-MS analysis of biological samples

Bioanalysis

Volumn 5, Issue 17, 2013, Pages 2101-2114

  Janusch, Franziska ^a   Kalthoff, Lena ^a   Hamscher, Gerd ^a   Mohring, Siegrun Ai ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; DIFLOXACIN; ENROFLOXACIN; MARBOFLOXACIN; PHOSPHOLIPID;

ACCURACY; ANALYTICAL PARAMETERS; ARTICLE; BODY FLUID; CHICKEN; CONCENTRATION RESPONSE; CONTROLLED STUDY; INTERMETHOD COMPARISON; LABORATORY DEVICE; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MATRIX EFFECT; NONHUMAN; PLASMA; SAMPLING;

EID: 84883064731     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.13.187     Document Type: Article

References (24)

1. Bonfiglio R, King RC, Olah TV, Merkle K. The effects of sample preparation methods on the variability of the electrospray ionization response for model drug compounds. Rapid Commun. Mass Spectrom. 13(12), 1175-1185 (1999).
2. Cech NB, Enke CG. Practical implications of some recent studies in electrospray ionization fundamentals. Mass Spectrom. Rev. 20(6), 362-387 (2001).
3. Liang HR, Foltz RL, Meng M, Bennett P. Ionization enhancement in atmospheric pressure chemical ionization and suppression in electrospray ionization between target drugs and stable-isotope-labeled internal standards in quantitative liquid chromatography/tandem mass spectrometry. Rapid Commun. Mass Spectrom. 17(24), 2815-2821 (2003).
4. Beaudry F, Vachon P. Electrospray ionization suppression, a physical or a chemical phenomenon? Biomed. Chromatogr. 20(2), 200-205 (2006).
5. Ismaiel OA, Halquist MS, Elmamly MY, Shalaby A, Thomas Karnes H. Monitoring phospholipids for assessment of ion enhancement and ion suppression in ESI and APCI LC-MS/MS for chlorpheniramine in human plasma and the importance of multiple source matrix effect evaluations. J. Chromatogr. B 875(2), 333-343 (2008).
6. Le Bizec B, Pinel G, Antignac JP. Options for veterinary drug analysis using mass spectrometry. J. Chromatogr. A 1216(46), 8016-8034 (2009).
7. Gosetti F, Mazzucco E, Zampieri D, Gennaro MC. Signal suppression/enhancement in high-performance liquid chromatography tandem mass spectrometry. J. Chromatogr. A 1217(25), 3929-3937 (2010).
8. Stahnke H, Reemtsma T, Alder L. Compensation of matrix effects by postcolumn infusion of a monitor substance in multiresidue analysis with LC-MS/MS. Anal. Chem. 81(6), 2185-2192 (2009).
9. Matuszewski BK, Constanzer ML, Chavez-Eng CM. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal. Chem. 75(13), 3019-3030 (2003).
10. Peterson BL, Cummings BS. A review of chromatographic methods for the assessment of phospholipids in biological samples. Biomed. Chromatogr. 20(3), 227-243 (2006).
11. Xia YQ, Jemal M. Phospholipids in liquid chromatography/mass spectrometry bioanalysis: comparison of three tandem mass spectrometric techniques for monitoring plasma phospholipids, the effect of mobile phase composition on phospholipids elution and the association of phospholipids with matrix effects. Rapid Commun. Mass Spectrom. 23(14), 2125-2138 (2009).
12. Pang LQ, Liang QL, Wang YM, Ping L, Luo GA. Simultaneous determination and quantification of seven major phospholipid classes in human blood using normal-phase liquid chromatography coupled with electrospray mass spectrometry and the application in diabetes nephropathy. J. Chromatogr. B 869(1-2), 118-125 (2008).
13. Christie WW, Moore JH. The lipid components of the plasma, liver and ovarian follicles in the domestic chicken (Gallus gallus). Comp. Biochem. Physiol. B Biochem. Mol. Biol. 41(2), 287-295 (1972).
14. Pulfer M, Murphy RC. Electrospray mass spectrometry of phospholipids. Mass Spectrom. Rev. 22(5), 332-364 (2003).
15. Zemski Berry KA, Murphy RC. Electrospray ionization tandem mass spectrometry of glycerophosphoethanolamine plasmalogen phospholipids. J. Am. Soc. Mass. Spectrom. 15(10), 1499-1508 (2004).
16. Little JL, Wempe MF, Buchanan CM. Liquid chromatography mass spectrometry mass spectrometry method development for drug metabolism studies examining lipid matrix ionization effects in plasma. J. Chromatogr. B 833(2), 219-230 (2006).
17. Uran S, Larsen A, Jacobsen PB, Skotland T. Analysis of phospholipid species in human blood using normal-phase liquid chromatography coupled with electrospray ionization ion-trap tandem mass spectrometry. J. Chromatogr. B 758(2), 265-275 (2001).
18. Wang C, Xie SG, Yang J, Yang Q, Xu GW. Structural identification of human blood phospholipids using liquid chromatography/quadrupole-linear ion trap mass spectrometry. Anal. Chim. Acta 525(1), 1-10 (2004).
19. Chambers E, Wagrowski-Diehl DM, Lu Z, Mazzeo J. Systematic and comprehensive strategy for reducing matrix effects in LC-MS/MS analyses. J. Chromatogr. B 852(1-2), 22-34 (2007).
20. Van Horne KC, Bennett P. Preventing matrix effects by using new sorbents to remove phospholipids from biological samples. Presented at: 2003 AAPS Annual Meeting and Exposition. Salt Lake City, Utah, 26-30 October 2003.
21. Van Eeckhaut A, Lanckmans K, Sarre S, Smolders I, Michotte Y. Validation of bioanalytical LC-MS/MS assays: evaluation of matrix effects. J. Chromatogr. B 877(23), 2198-2207 (2009).
22. Martinez M, Mcdermott P, Walker R. Pharmacology of the fluoroquinolones: a perspective for the use in domestic animals. Vet. J. 172(1), 10-28 (2006).
23. Tyczkowska K, Hedeen KM, Aucoin DP, Aronson AL. High-performance liquid chromatographic method for the simultaneous determination of enrofloxacin and its primary metabolite ciprofloxacin in canine serum and prostatic tissue. J. Chromatogr. 493(2), 337-346 (1989).
24. Lahaie M, Mess JN, Furtado M, Garofolo F. Elimination of LC-MS/MS matrix effect due to phospholipids using specific solid-phase extraction elution conditions. Bioanalysis 2(6), 1011-1021 (2010).